The Global Mass Spectrometry Software Market is projected to reach $9,216.13 million by 2028, from a value of $5,840.09 million in 2022, by registering a CAGR of 7.9% during the forecast period. Increase in the focus on the quality of food products among population, increasing implementation of various regulations and compliances regarding the reduction of pollution levels and consistent testing of environment by various authorities, and rise in spending on pharmaceutical research and development are the major factors propelling the growth of the market. However, dearth of skilled professionals and high cost associated with the systems are hampering market growth. Moreover, increase in technological advancements in mass spectrometers across the globe and rise in the government initiatives for pollution control and environmental testing are creating ample opportunities across the globe.
Recent Developments
In June 2022, Agilent Technologies Inc announced it will use Amazon Elastic Compute Cloud (Amazon EC2) G5g instances powered by Amazon Web Services (AWS) Graviton2 processors and featuring NVIDIA T4G Tensor Core GPUs, in combination with NVIDIA Clara Parabricks’ advanced genomics analysis capabilities, to significantly improve processing speeds for variant calling workflows on Agilent’s cloud-native Alissa Reporter software.
In June 2022, Bruker Corporation has launched PhenoRiskPACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson.
In June 2021, Genedata announced Sophion Bioscience as a new Genedata Ready-to-Run partner. Sophion joins a continually expanding group of leading technology providers who collaborate with Genedata to offer standardized integrations with the Genedata Biopharma Platform. The deep integration of Sophion QPatch II and Qube 384 APC instruments with Genedata Screener® enables direct capture, remote analysis, and enterprise access to APC data’s highly informative mechanistic and safety aspects of tested molecules.
In May 2022, PerkinElmer, Inc announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics. This addition to the Company’s portfolio of whole genome sequencing (WGS) offerings provides physicians with comprehensive, meaningful results in five days to help inform clinical management and improve outcomes for critically ill patients in neonatal and pediatric intensive care units (NICUs and PICUs).
Competitive Landscape
AB Sciex Pte Ltd, Adaptas Solutions, Advanced Chemistry Development, Agilent Technologies, Inc, Bruker, Genedata AG, Lablicate GmbH, Max-Planck-Institute of Biochemistry, Microsaic Systems plc, MS Wil B.V, OpenMS, PerkinElmer, Inc, Shimadzu Scientific Instruments, SpectralWorks Ltd, Thermo Fisher Scientific Inc, and Waters Corporation are some of the major players in the global Mass Spectrometry Software market.
